Literature DB >> 32211749

Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?

Emma M van Andel1, Brechtje D M Koopmann1, Femke Crouwel1, Casper G Noomen1, Nanne K H de Boer2, Dirk P van Asseldonk1, Lidwine B Mokkink3.   

Abstract

BACKGROUND AND AIMS: Patient-reported outcome measures are increasingly important in daily care and research in inflammatory bowel disease [IBD]. This study provides an overview of the content and content validity of IBD-specific patient-reported outcome measures on three selected constructs.
METHODS: Databases were searched up to May 2019 for development and/or content validity studies on IBD-specific self-report measures on health-related quality of life, disability, and self-report disease activity in adults. Evidence was synthesised on content validity in three aspects: relevance, comprehensiveness, and comprehensibility following the COnsensus-based Standards for the selection of health Measurement INstruments methodology. Questionnaire items were organised in themes to provide an overview of important aspects of these constructs.
RESULTS: For 14/44 instruments, 25 content validity studies were identified and 25/44 measures had sufficient content validity, the strongest evidence being of moderate quality, though most evidence is of low or very low quality. The Crohn's Life Impact Questionnaire and IBD questionnaire-32 on quality of life, the IBD-Control on disease activity, and the IBD Disability Index Self-Report and its 8-item version on disability, have the strongest evidence of sufficient relevance, comprehensiveness, and comprehensibility, ranging from moderate to very low quality. A fair number of recurring items themes, possibly important for the selected constructs, was identified.
CONCLUSIONS: The body of evidence for content validity of IBD-specific health-related quality of life, self-report disease activity, and disability self-report measures is limited. More content validity studies should be performed after reaching consensus on the constructs of interest for IBD, and studies should involve patients.
© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

Entities:  

Keywords:  Content validity; inflammatory bowel diseases; patient-reported outcome measures

Mesh:

Year:  2020        PMID: 32211749      PMCID: PMC7493218          DOI: 10.1093/ecco-jcc/jjaa057

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  77 in total

1.  Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Authors:  Donald L Patrick; Laurie B Burke; Chad J Gwaltney; Nancy Kline Leidy; Mona L Martin; Elizabeth Molsen; Lena Ring
Journal:  Value Health       Date:  2011-10-10       Impact factor: 5.725

2.  Quality of life in inflammatory bowel disease.

Authors:  J R Love; E J Irvine; R N Fedorak
Journal:  J Clin Gastroenterol       Date:  1992-01       Impact factor: 3.062

Review 3.  Quality of life of patients with ulcerative colitis: past, present, and future.

Authors:  E Jan Irvine
Journal:  Inflamm Bowel Dis       Date:  2008-04       Impact factor: 5.325

4.  [Tunisian version validation of quality life's questionnaire for chronic inflammatory disease of intestine].

Authors:  L Mnif; M Medhioub; M Boudabbous; L Chtourou; A Amouri; N Tahri
Journal:  Tunis Med       Date:  2013-12

5.  Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.

Authors:  Jiayin Ruan; Yan Chen; Yunxian Zhou
Journal:  Inflamm Bowel Dis       Date:  2017-03       Impact factor: 5.325

6.  An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.

Authors:  Meenakshi Bewtra; Colleen M Brensinger; Vesselin T Tomov; Tram B Hoang; Carly E Sokach; Corey A Siegel; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

7.  Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.

Authors:  Mercedes Vergara; Beatriz Sicilia; Luis Prieto; Francesc Casellas; Alexis Ramos; Fernando Gomollón; Xavier Calvet
Journal:  Inflamm Bowel Dis       Date:  2016-04       Impact factor: 5.325

8.  Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort.

Authors:  Corinne Gower-Rousseau; Hélène Sarter; Guillaume Savoye; Noémie Tavernier; Mathurin Fumery; William J Sandborn; Brian G Feagan; Alain Duhamel; Nathalie Guillon-Dellac; Jean-Frédéric Colombel; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2015-12-08       Impact factor: 23.059

9.  Questions on life satisfaction (FLZM) in inflammatory bowel disease.

Authors:  K-H Janke; A Raible; M Bauer; P Clemens; C Meisner; W Häuser; U Steder-Neukamm; G Henrich; P Herschbach; M Gregor; B Klump
Journal:  Int J Colorectal Dis       Date:  2003-10-28       Impact factor: 2.571

10.  Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health.

Authors:  Laurent Peyrin-Biroulet; Alarcos Cieza; William J Sandborn; Michaela Coenen; Yehuda Chowers; Toshifumi Hibi; Nenad Kostanjsek; Gerold Stucki; Jean-Frédéric Colombel
Journal:  Gut       Date:  2011-06-05       Impact factor: 23.059

View more
  4 in total

Review 1.  Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment.

Authors:  Cristina Calviño-Suárez; Rocío Ferreiro-Iglesias; Iria Bastón-Rey; Manuel Barreiro-de Acosta
Journal:  Int J Environ Res Public Health       Date:  2021-07-04       Impact factor: 3.390

Review 2.  Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives.

Authors:  Florian Tran; Jan Henrik Schirmer; Ilka Ratjen; Wolfgang Lieb; Philip Helliwell; Johan Burisch; Juliane Schulz; Florian Schrinner; Charlot Jaeckel; Ulf Müller-Ladner; Stefan Schreiber; Bimba F Hoyer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

3.  Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?

Authors:  Ashkan Rezazadeh Ardabili; Evelien M B Hendrix; Marie J Pierik
Journal:  J Crohns Colitis       Date:  2021-05-04       Impact factor: 9.071

4.  Impaired Quality of Working Life in Inflammatory Bowel Disease Patients.

Authors:  Sara van Gennep; Nanne K H de Boer; Marieke E Gielen; Svend T Rietdijk; Krisztina B Gecse; Cyriel Y Ponsioen; Marjolijn Duijvestein; Geert R D'Haens; Mark Löwenberg; Angela G E M de Boer
Journal:  Dig Dis Sci       Date:  2020-10-16       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.